麻豆原创

The global Experimental Monkey market was valued at US$ 2448 million in 2023 and is anticipated to reach US$ 3749 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
Experimental monkeys, particularly macaques such as Cynomolgus macaques (Macaca fascicularis) and Rhesus monkeys (Macaca mulatta), have long been indispensable models for scientific research. These monkeys are primarily used in the fields of biology, medicine, neuroscience, and drug development due to their close physiological and genetic similarity to humans, particularly in the nervous system. The use of primates as experimental models has played a critical role in advancing our understanding of biological and physiological processes, disease mechanisms, and the development of new medical treatments.
麻豆原创 Overview:
The experimental monkey market is largely driven by the demand for Cynomolgus macaques and Rhesus monkeys, which account for the bulk of primates used in scientific research. While other species of monkeys are also used, these two types are most commonly used due to their availability, affordability, and physiological similarities to humans. The market is segmented by species (e.g., Cynomolgus macaques and Rhesus monkeys) and by application (e.g., Contract Research and Development Organizations (CROs), research institutions, and universities).
Cynomolgus Macaques: These are the most commonly used monkeys in medical and pharmaceutical research due to their smaller size, docile nature, and genetic resemblance to humans. They are often preferred for preclinical research, immunology studies, and vaccine testing.
Rhesus Monkeys: These monkeys are larger in size and more aggressive than Cynomolgus macaques, but they share a similar genetic structure with humans. They are often used in neuroscience research and brain function studies due to their cognitive and neurological similarities to humans.
The market is dominated by Contract Research Organizations (CROs), which provide comprehensive research and testing services for pharmaceutical companies and other stakeholders in the healthcare industry. Other major players in the market include research institutions, universities, and pharmaceutical companies, who rely on experimental monkeys to test and validate new treatments, drugs, and therapies.
麻豆原创 Drivers:
Increased Demand for Biomedical Research and Drug Development
The primary driver for the growth of the experimental monkey market is the increasing demand for biomedical research and drug development. As the pharmaceutical industry expands, the need for non-human primates as models for preclinical research grows. Monkeys are crucial for understanding complex human diseases such as Alzheimer's, Parkinson's, HIV, and cancer, and are used extensively in drug safety testing, efficacy testing, and vaccine development.
For instance, the rapid development of vaccines for diseases such as COVID-19, Zika, and HIV has led to an increasing reliance on primates for testing and validation. As biopharmaceutical companies work to develop new therapeutics and vaccines, the need for high-quality, well-maintained experimental monkeys has increased significantly.
Rising Demand from Contract Research Organizations (CROs)
CROs are one of the largest consumer segments in the experimental monkey market. CROs provide outsourced research services to pharmaceutical and biotechnology companies, ranging from drug discovery to clinical trials. These organizations often rely on experimental monkeys for preclinical testing, including studies on drug toxicity, pharmacokinetics, and pharmacodynamics. As the demand for outsourcing drug development and research activities increases, so too does the need for experimental animals, particularly non-human primates like monkeys.
Increasing Focus on Personalized Medicine and Immunology
Another key driver of the experimental monkey market is the rise of personalized medicine and immunology. Personalized medicine focuses on tailoring medical treatment to individual patients based on their genetic makeup, and primates are used to model human genetic diversity and immune responses. Additionally, non-human primates are vital in immunology research, particularly in studies on the immune system鈥檚 response to pathogens and vaccines.
The demand for high-quality experimental monkeys will continue to rise as more pharmaceutical companies focus on personalized, genetically-driven treatments and more research is conducted in the fields of immunotherapy and gene therapy.
麻豆原创 Restraints:
Ethical and Animal Welfare Concerns
One of the primary constraints on the growth of the experimental monkey market is the increasing concern over animal welfare and the ethics of using primates in scientific research. Non-human primates, especially those that are genetically similar to humans, are often seen as having higher cognitive and emotional capacities, which raises ethical concerns regarding their use in experiments. Public opinion and regulatory scrutiny regarding animal testing have been tightening globally, leading to stricter regulations on the use of primates in research.
Many countries and institutions have established stringent ethical guidelines to ensure that animal experiments are conducted humanely and that alternative methods are explored before resorting to primate research. These concerns have led to an increase in advocacy for alternative testing methods, such as in vitro testing and computer models, although these cannot fully replicate the complex biological systems that primates offer.
High Cost of Maintenance and Breeding
The high cost associated with breeding, maintaining, and housing experimental monkeys is another significant restraint. Primates are expensive to breed and care for, and their long gestation periods and high susceptibility to diseases make their maintenance particularly challenging. Ensuring the health and well-being of experimental monkeys requires significant financial and logistical resources, which may limit their widespread use in certain regions.
In addition, the breeding of genetically diverse and healthy monkeys for research purposes is a complex and expensive process. The cost of maintaining these monkeys in specialized environments with the necessary veterinary care and facilities further adds to the financial burden.
Limited Availability of High-Quality Monkeys
While the demand for experimental monkeys is high, the availability of high-quality, disease-free monkeys is limited. Primates are in short supply, particularly those that meet the high standards required for biomedical research. Ethical concerns, as well as the geographical location of breeding facilities, also limit the accessibility of monkeys for research purposes. This has led to price fluctuations and delays in the availability of monkeys for research, particularly in certain regions.
Regulatory Challenges
The use of experimental monkeys is heavily regulated by national and international laws. Different countries have different regulations regarding the use of non-human primates in scientific research. For example, the European Union has strict laws concerning animal testing, which limit the number of primates that can be used for research purposes. In contrast, the United States and other countries have more lenient regulations, although ethical and welfare concerns are still prominent. This regulatory landscape can limit the market for experimental monkeys, particularly in regions with stricter laws.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Experimental Monkey, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Experimental Monkey.
The Experimental Monkey market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Experimental Monkey market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Experimental Monkey manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Vanny Bio Research
HZ-Bio
Envigo (Inotiv)
JOINN LABORATORIES
WuXi AppTec
Jingang Biotech
Charles River
Pharmaron
Xishan Zhongke
ONPRC (Oregon National Primate Research Center)
CNPRC (California National Primate Research Center)
Sichuan Hengshu Bio-Technolog
Topgene Biotechnology
Primate Products, Inc. (PPI)
Sichuan Green-House Biotech
Segment by Type
Macaca Fascicularis (Cynomolgus Macaque)
Rhesus Monkey (Macaca Mulatta)
Others
Segment by Application
Contract Research and Development Service Organization (CRO) Company
Scientific Research Institution
Colleges and Universities
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Experimental Monkey manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Experimental Monkey in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.